恶性血液病-话题@MedSci

#恶性血液病#

19篇内容 | 771人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1515153, encodeId=82bb151515343, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=【4月25日（周一）19:00星光奕奕】CAR-T中国病例分享会即将开始！——当CAR-T之光照进现实，恶性血液病的临床治愈将成为可能！, objectType=article, longId=724918, objectId=d4d0e249186c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4d0e249186c, replyNumber=0, likeNumber=41, createdTime=2022-04-26, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4d0e249186c, moduleTitle=【4月25日（周一）19:00星光奕奕】CAR-T中国病例分享会即将开始！——当CAR-T之光照进现实，恶性血液病的临床治愈将成为可能！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4d0e249186c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515152, encodeId=946215151522a, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=EClinicalMed：与恶性血液病患者造血干细胞移植后的结果相关的新遗传变异位点！, objectType=article, longId=216577, objectId=ae862165e771, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae862165e771, replyNumber=0, likeNumber=40, createdTime=2021-09-03, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae862165e771, moduleTitle=EClinicalMed：与恶性血液病患者造血干细胞移植后的结果相关的新遗传变异位点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae862165e771)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515151, encodeId=63fb1515151f8, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=2021年恶性血液病患者药物性肝损伤防治共识，3分钟get要点！, objectType=article, longId=214564, objectId=6d7a2145649e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d7a2145649e, replyNumber=0, likeNumber=45, createdTime=2021-07-23, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d7a2145649e, moduleTitle=2021年恶性血液病患者药物性肝损伤防治共识，3分钟get要点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d7a2145649e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515150, encodeId=85fb151515066, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle= Blood：3377例汇总分析 | 感染新冠病毒的恶性血液病患者的预后, objectType=article, longId=203241, objectId=26b6203241a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26b6203241a2, replyNumber=0, likeNumber=31, createdTime=2020-11-12, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26b6203241a2, moduleTitle= Blood：3377例汇总分析 | 感染新冠病毒的恶性血液病患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26b6203241a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515149, encodeId=83f3151514992, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=Blood：采用HSCT治疗的恶性血液病患儿的长期预后, objectType=article, longId=191552, objectId=8f6319155265, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f6319155265, replyNumber=0, likeNumber=32, createdTime=2020-04-07, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f6319155265, moduleTitle=Blood：采用HSCT治疗的恶性血液病患儿的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f6319155265)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515148, encodeId=260115151482a, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=Blood：Hippo激酶缺失通过慢性激活固有免疫促进del（20q）相关性恶性血液病的进展, objectType=article, longId=178188, objectId=04e21e81883a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04e21e81883a, replyNumber=0, likeNumber=53, createdTime=2019-08-27, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04e21e81883a, moduleTitle=Blood：Hippo激酶缺失通过慢性激活固有免疫促进del（20q）相关性恶性血液病的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04e21e81883a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515147, encodeId=4674151514e5e, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=Blood：HCT-CI评分可预测非恶性血液病患者进行造血细胞移植后的死亡风险, objectType=article, longId=157423, objectId=953415e4233d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=953415e4233d, replyNumber=0, likeNumber=36, createdTime=2019-01-07, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=953415e4233d, moduleTitle=Blood：HCT-CI评分可预测非恶性血液病患者进行造血细胞移植后的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=953415e4233d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515146, encodeId=ffe61515146c8, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=周剑峰教授：CAR-T治疗在难治恶性血液病中的临床进展, objectType=article, longId=155728, objectId=a849155e285a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a849155e285a, replyNumber=0, likeNumber=44, createdTime=2018-12-15, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a849155e285a, moduleTitle=周剑峰教授：CAR-T治疗在难治恶性血液病中的临床进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a849155e285a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515145, encodeId=53191515145ad, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估, objectType=article, longId=132551, objectId=bc0a132551d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0a132551d5, replyNumber=0, likeNumber=24, createdTime=2018-03-17, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0a132551d5, moduleTitle=Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0a132551d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515144, encodeId=e5e11515144a8, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=Blood：IL-15强兴奋剂复合物ALT-803用于干细胞移植后复发的恶性血液病的效果, objectType=article, longId=130269, objectId=e0641302692b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0641302692b, replyNumber=0, likeNumber=23, createdTime=2018-02-23, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0641302692b, moduleTitle=Blood：IL-15强兴奋剂复合物ALT-803用于干细胞移植后复发的恶性血液病的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0641302692b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515143, encodeId=6ed3151514371, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=Lancet haemat：恶性血液病患者进行干细胞移植后的亚临床影像。, objectType=article, longId=123493, objectId=bae612349398, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bae612349398, replyNumber=0, likeNumber=34, createdTime=2017-12-16, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bae612349398, moduleTitle=Lancet haemat：恶性血液病患者进行干细胞移植后的亚临床影像。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bae612349398)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515142, encodeId=4796151514291, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=王昱副主委：移植后恶性血液病的复发及处理, objectType=article, longId=116694, objectId=2245116694d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2245116694d2, replyNumber=0, likeNumber=0, createdTime=2017-10-20, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2245116694d2, moduleTitle=王昱副主委：移植后恶性血液病的复发及处理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2245116694d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515141, encodeId=b2cd1515141bd, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=J Oncol Pharm Pract：发热性中性粒细胞减少恶性血液病患者抗生素给药时间影响结局？, objectType=article, longId=114675, objectId=e13a1146e5ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e13a1146e5ed, replyNumber=0, likeNumber=34, createdTime=2017-09-30, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e13a1146e5ed, moduleTitle=J Oncol Pharm Pract：发热性中性粒细胞减少恶性血液病患者抗生素给药时间影响结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e13a1146e5ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515140, encodeId=35e2151514020, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=Blood：美国70岁及以上的恶性血液病患者接受异体造血干细胞移植的情况, objectType=article, longId=104588, objectId=e3be1045887e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3be1045887e, replyNumber=0, likeNumber=37, createdTime=2017-07-06, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3be1045887e, moduleTitle=Blood：美国70岁及以上的恶性血液病患者接受异体造血干细胞移植的情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3be1045887e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515139, encodeId=3e341515139bf, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=Oncologist：异基因移植治疗恶性血液病的供者选择：人人享有供者？, objectType=article, longId=100609, objectId=3980100609af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3980100609af, replyNumber=0, likeNumber=40, createdTime=2017-06-04, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3980100609af, moduleTitle=Oncologist：异基因移植治疗恶性血液病的供者选择：人人享有供者？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3980100609af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515138, encodeId=7241151513877, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=儿童恶性血液病脐带血移植专家共识, objectType=article, longId=92469, objectId=6e869246941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e869246941, replyNumber=0, likeNumber=0, createdTime=2017-03-21, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e869246941, moduleTitle=儿童恶性血液病脐带血移植专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e869246941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515137, encodeId=8eb6151513ea6, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=浙医一院CAR-T治疗恶性血液病进展振奋中美法专家, objectType=article, longId=90322, objectId=f3ef90322f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3ef90322f6, replyNumber=0, likeNumber=45, createdTime=2017-03-03, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3ef90322f6, moduleTitle=浙医一院CAR-T治疗恶性血液病进展振奋中美法专家, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3ef90322f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515136, encodeId=e13d151513680, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=儿童恶性血液病脐带血移植专家共识, objectType=article, longId=84715, objectId=185984e15fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=185984e15fe, replyNumber=0, likeNumber=30, createdTime=2016-12-21, rootId=0, userName=ms9608593228839890, userId=f4dc10724136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=185984e15fe, moduleTitle=儿童恶性血液病脐带血移植专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=185984e15fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1515135, encodeId=fc2b151513510, content=<a href='/topic/show?id=7acc52955b3' target=_blank style='color:#2F92EE;'>#恶性血液病#</a>, objectTitle=Lancet Haematol：PF-04449913治疗髓系恶性血液病患者的研究, objectType=article, longId=53824, objectId=9a0953824b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a0953824b2, replyNumber=0, likeNumber=32, createdTime=2015-07-29, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a0953824b2, moduleTitle=Lancet Haematol：PF-04449913治疗髓系恶性血液病患者的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a0953824b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

恶性血液病

2020-05-29

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

【4月25日（周一）19:00星光奕奕】CAR-T中国病例分享会即将开始！——当CAR-T之光照进现实，恶性血液病的临床治愈将成为可能！

2022-04-26

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

EClinicalMed：与恶性血液病患者造血干细胞移植后的结果相关的新遗传变异位点！

2021-09-03

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

2021年恶性血液病患者药物性肝损伤防治共识，3分钟get要点！

2021-07-23

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

Blood：3377例汇总分析 | 感染新冠病毒的恶性血液病患者的预后

2020-11-12

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

Blood：采用HSCT治疗的恶性血液病患儿的长期预后

2020-04-07

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

Blood：Hippo激酶缺失通过慢性激活固有免疫促进del（20q）相关性恶性血液病的进展

2019-08-27

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

Blood：HCT-CI评分可预测非恶性血液病患者进行造血细胞移植后的死亡风险

2019-01-07

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

周剑峰教授：CAR-T治疗在难治恶性血液病中的临床进展

2018-12-15

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估

2018-03-17

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

Blood：IL-15强兴奋剂复合物ALT-803用于干细胞移植后复发的恶性血液病的效果

2018-02-23

zhouqu_8 (审核中...)

前往app查看评论内容

#恶性血液病#

Lancet haemat：恶性血液病患者进行干细胞移植后的亚临床影像。

2017-12-16

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

王昱副主委：移植后恶性血液病的复发及处理

2017-10-20

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

J Oncol Pharm Pract：发热性中性粒细胞减少恶性血液病患者抗生素给药时间影响结局？

2017-09-30

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

Blood：美国70岁及以上的恶性血液病患者接受异体造血干细胞移植的情况

2017-07-06

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

Oncologist：异基因移植治疗恶性血液病的供者选择：人人享有供者？

2017-06-04

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

儿童恶性血液病脐带血移植专家共识

2017-03-21

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

浙医一院CAR-T治疗恶性血液病进展振奋中美法专家

2017-03-03

ms9608593228839890 (审核中...)

前往app查看评论内容

#恶性血液病#

儿童恶性血液病脐带血移植专家共识

2016-12-21

zhaojie88 (审核中...)

前往app查看评论内容

#恶性血液病#

Lancet Haematol：PF-04449913治疗髓系恶性血液病患者的研究

2015-07-29

科室
- - 订阅+
  - 更多科室
工具
服务